Clinical Trial

A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
To assess the effectiveness of Amisulpride to treat Post Operative Nausea and Vomiting (PONV) and to assess the effectiveness of Amisulpride to prevent PONV following bariatric surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-03.
Status change: Not Yet Recruiting → Recruiting 2024-09-24
Trial Details
NCT Number NCT06585540
Lead Sponsor Benaroya Research Institute
Collaborators: Virginia Mason Hospital/Medical Center
Conditions Post Operative Nausea and Vomiting
Enrollment 100 participants
Start Date 2024-09-13
Primary Completion 2025-09 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-26